|
Valoración de DCF VolitionRX Limited (VNRX)
US | Healthcare | Medical - Diagnostics & Research | AMEX
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
VolitionRx Limited (VNRX) Bundle
¡Descubra el verdadero potencial de VolitionRX Limited (VNRX) con nuestra calculadora DCF avanzada! Ajuste los supuestos esenciales, explore varios escenarios y evalúe los efectos de los cambios en la valoración de VolitionRX Limited (VNRX), todo dentro de una sola plantilla de Excel.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .1 | .3 | .8 | 1.3 | 2.2 | 3.8 | 6.4 | 10.9 |
| Revenue Growth, % | 0 | -21.43 | 570.25 | 240.3 | 153.04 | 69.64 | 69.64 | 69.64 | 69.64 | 69.64 |
| EBITDA | -15.1 | -19.2 | -25.7 | -29.2 | -34.0 | -1.3 | -2.2 | -3.8 | -6.4 | -10.9 |
| EBITDA, % | -88149.71 | -143140.95 | -28532.04 | -9542.34 | -4391.04 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | .9 | 1.0 | 1.1 | 1.2 | 1.4 | 1.3 | 2.2 | 3.8 | 6.4 | 10.9 |
| Depreciation, % | 5278.5 | 7752.35 | 1271.91 | 387.88 | 182.29 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -16.0 | -20.3 | -26.8 | -30.4 | -35.5 | -1.3 | -2.2 | -3.8 | -6.4 | -10.9 |
| EBIT, % | -93428.21 | -150893.3 | -29803.95 | -9930.21 | -4573.33 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 17.0 | 19.4 | 20.6 | 10.9 | 20.7 | 1.3 | 2.2 | 3.8 | 6.4 | 10.9 |
| Total Cash, percent | .1 | .1 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .1 | .2 | .3 | .5 | .9 | 1.6 | 2.7 |
| Account Receivables, % | 0 | 52.99 | 13.89 | 23.7 | 31.29 | 24.37 | 24.37 | 24.37 | 24.37 | 24.37 |
| Inventories | .0 | .3 | .6 | .8 | .0 | .8 | 1.3 | 2.3 | 3.9 | 6.5 |
| Inventories, % | 0 | 2256.96 | 664.59 | 256.18 | 0 | 60 | 60 | 60 | 60 | 60 |
| Accounts Payable | .6 | 1.5 | 1.5 | 3.0 | 3.2 | 1.3 | 2.2 | 3.8 | 6.4 | 10.9 |
| Accounts Payable, % | 3669 | 11460.93 | 1713.17 | 993.17 | 414.2 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | -.5 | -1.9 | -1.0 | -1.6 | -1.1 | -1.3 | -2.2 | -3.8 | -6.4 | -10.9 |
| Capital Expenditure, % | -2990.56 | -14449.94 | -1081.31 | -512.47 | -139.78 | -100 | -100 | -100 | -100 | -100 |
| Tax Rate, % | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EBITAT | -15.9 | -20.4 | -26.8 | -30.1 | -35.1 | -1.3 | -2.2 | -3.8 | -6.4 | -10.8 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -14.9 | -20.6 | -26.9 | -29.2 | -34.0 | -4.1 | -2.1 | -3.5 | -6.0 | -10.1 |
| WACC, % | 9.04 | 9.04 | 9.04 | 9.04 | 9.04 | 9.04 | 9.04 | 9.04 | 9.04 | 9.04 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -19.0 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -10 | |||||||||
| Terminal Value | -147 | |||||||||
| Present Terminal Value | -95 | |||||||||
| Enterprise Value | -114 | |||||||||
| Net Debt | -15 | |||||||||
| Equity Value | -99 | |||||||||
| Diluted Shares Outstanding, MM | 71 | |||||||||
| Equity Value Per Share | -1.40 |
What You Will Receive
- Authentic VNRX Financial Data: Pre-populated with VolitionRx Limited’s historical and forecasted data for accurate analysis.
- Completely Customizable Template: Easily adjust essential inputs such as revenue growth, WACC, and EBITDA %.
- Instant Calculations: Watch the intrinsic value of VNRX update in real-time as you make modifications.
- Expert Valuation Tool: Tailored for investors, analysts, and consultants aiming for precise DCF outcomes.
- Intuitive Design: User-friendly layout and straightforward guidelines suitable for all skill levels.
Key Features
- Customizable Financial Inputs: Adjust essential metrics such as revenue projections, gross margins, and R&D expenses.
- Instant DCF Valuation: Automatically computes intrinsic value, net present value, and additional financial metrics.
- High-Precision Analysis: Leverages VolitionRx's actual financial data for accurate valuation results.
- Streamlined Scenario Testing: Easily evaluate various assumptions and analyze different outcomes.
- Efficiency Booster: Avoid the complexity of constructing intricate valuation models from the ground up.
How It Works
- Download the Template: Get instant access to the Excel-based VNRX DCF Calculator.
- Input Your Assumptions: Adjust the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
- Instant Calculations: The model automatically updates VolitionRx's intrinsic value.
- Test Scenarios: Simulate various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the results to inform your investment or financial analysis.
Why Choose This Calculator for VolitionRx Limited (VNRX)?
- All-in-One Solution: Offers DCF, WACC, and financial ratio analyses tailored for VolitionRx Limited (VNRX).
- Flexible Parameters: Modify the highlighted cells to explore different financial scenarios.
- In-Depth Analysis: Automatically computes VolitionRx Limited’s (VNRX) intrinsic value and Net Present Value.
- Preloaded Information: Historical and projected data provide reliable foundations for analysis.
- Expert-Level Tool: Perfect for financial analysts, investors, and consultants focused on VolitionRx Limited (VNRX).
Who Should Use VolitionRx Limited (VNRX)?
- Investors: Gain insights and make informed decisions with advanced diagnostic tools.
- Healthcare Professionals: Utilize innovative technology to improve patient outcomes and diagnostics.
- Researchers: Adapt our solutions for clinical studies and data analysis.
- Biotech Enthusiasts: Explore the latest advancements in cancer detection and diagnostics.
- Educators and Students: Leverage real-world applications of biotechnology in academic settings.
What the Template Contains
- Historical Data: Includes VolitionRx Limited's (VNRX) past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate VolitionRx Limited's (VNRX) intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of VolitionRx Limited's (VNRX) financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.